← Back to headlines
Summit Therapeutics Rises as Akeso Wins China Drug Label Expansion
Summit Therapeutics saw its stock rise after its partner Akeso secured a label expansion in China for its leading drug, indicating positive regulatory developments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
